EchoGo® Heart Failure vs Ligence Heart

When choosing between Ultromics’ EchoGo® Heart Failure and Ligence Heart, physicians should consider their primary need: specialized HFpEF detection or comprehensive echocardiogram automation. EchoGo® Heart Failure excels in the specific, rapid detection of Heart Failure with preserved Ejection Fraction (HFpEF), providing insights within 20 minutes from routine echocardiograms. It offers a binary prediction and a probability score for HFpEF, aiming to reduce diagnostic uncertainty and potentially minimize unnecessary invasive testing. This tool is particularly suited for practices focused on improving HFpEF diagnosis and management, especially given its dedicated CPT code for reimbursement.

In contrast, Ligence Heart offers a broader automation of 2D transthoracic echocardiography analysis and reporting, encompassing automated view classification, heart phase prediction, and comprehensive measurement calculations for various cardiac conditions, including heart failure, cardiomyopathy, pulmonary hypertension, and valvular heart diseases. The key practical difference lies in their scope: EchoGo® Heart Failure is a specialized diagnostic aid for HFpEF, while Ligence Heart is a workflow enhancement tool designed to automate much of the manual effort in echocardiogram interpretation and reporting across a wider range of pathologies.

Therefore, a physician or health system prioritizing a dedicated, rapid, and reimbursable solution for HFpEF detection would likely find EchoGo® Heart Failure more aligned with their needs. For those seeking to significantly streamline and automate the entire echocardiography analysis and reporting workflow for diverse cardiac conditions, thereby improving efficiency and reducing variability in measurements, Ligence Heart would be the more appropriate choice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist